Valuation: Bayer AG

Market Cap 46.85B 53.32B 43.73B 40.14B 75.13B 5,107B 76.98B 519B 203B 2,527B 200B 196B 8,737B P/E 2026 *
20.6x
P/E 2027 * 15.4x
Enterprise Value 78.69B 89.56B 73.45B 67.41B 126B 8,578B 129B 871B 341B 4,245B 336B 329B 14,674B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.48%
Yield 2027 * 1.32%
1 week+1.84%
Current month-1.49%
1 month+3.83%
3 months+31.55%
6 months+8.31%
Current year+28.40%
1 week 45.54
Extreme 45.54
48.57
1 month 45.54
Extreme 45.54
53.86
3 years 18.43
Extreme 18.43
53.86
5 years 18.43
Extreme 18.43
67.96
10 years 18.43
Extreme 18.43
123.8
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 60 2017-03-31
Chairman 68 2020-04-27
Change 5-day change 1-year change 3-year change Capi.($)
+2.01%+1.84%+66.87%-9.18% 53.32B
-4.21%-2.13%+52.70%+155.33% 1,079B
-3.52%-1.33%+52.95%+52.71% 640B
-2.72%-0.50%+35.04%+70.90% 465B
-2.23%+1.34%+36.44%+30.89% 353B
-2.23%-0.60%+33.55%+39.34% 301B
-2.97%+0.55%+10.96%+14.05% 271B
-2.12%+3.31%+1.82%-39.41% 228B
-1.64%+2.37%+26.19%+62.42% 209B
-2.47%-1.38%+12.45%+69.49% 165B
Average -2.75%+4.83%+32.90%+44.66% 412.19B
Weighted average by Cap. -3.22%+4.86%+38.39%+73.32%

Financials

2026 *2027 *
Net sales 45.6B 51.9B 42.57B 39.07B 73.13B 4,971B 74.93B 505B 197B 2,460B 195B 191B 8,504B 46.76B 53.21B 43.64B 40.05B 74.98B 5,097B 76.83B 518B 202B 2,522B 200B 195B 8,719B
Net income 2.13B 2.42B 1.98B 1.82B 3.41B 232B 3.49B 23.53B 9.2B 115B 9.08B 8.89B 396B 2.93B 3.34B 2.74B 2.51B 4.7B 320B 4.82B 32.46B 12.69B 158B 12.53B 12.26B 547B
Net Debt 31.84B 36.24B 29.72B 27.28B 51.06B 3,471B 52.32B 352B 138B 1,718B 136B 133B 5,938B 28.71B 32.68B 26.8B 24.6B 46.04B 3,130B 47.18B 318B 124B 1,549B 123B 120B 5,354B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
26-07-30 48.40 +1.92%
26-07-29 €47.49 +0.94%
26-07-28 €47.05 -0.51%
26-07-27 €47.29 +3.03%
26-07-24 €45.90 -0.35%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.69EUR
Average target price
54.92EUR
Spread / Average Target
+15.15%

Quarterly revenue - Rate of surprise